Predicted protein targets (top 2)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.35 |
| ▸ | MAPT | P10636 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6809069 | 0.98 | L3MBTL1 (0.34) | L3MBTL1MAPT | |
| SCHEMBL6809261 | 0.98 | L3MBTL1 (0.34) | L3MBTL1MAPT | |
| SCHEMBL7587420 | 0.98 | L3MBTL1 (0.34) | L3MBTL1MAPT | |
| SCHEMBL12769537 | 0.84 | L3MBTL1 (0.31) | L3MBTL1MAPT | |
| SCHEMBL12049857 | 0.84 | L3MBTL1 (0.31) | L3MBTL1MAPT | |
| SCHEMBL26225901 | 0.81 | — | — | |
| SCHEMBL26760004 | 0.81 | — | — | |
| SCHEMBL21563220 | 0.80 | LGALS8 (0.31) | — | |
| SCHEMBL7141087 | 0.79 | L3MBTL1 (0.53) | L3MBTL1MAPT | |
| SCHEMBL13625826 | 0.78 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-112384523-B | Ribose cationic lipids | 川斯勒佰尔公司 | 2025-03-14 | — | — | CN | disclosed |
| US-20240374521-A1 | RIBOSE CATIONIC LIPIDS | TRANSLATE BIO INC (US) | 2024-11-14 | — | — | US | disclosed |
| US-11964051-B2 | Ribose cationic lipids | TRANSLATE BIO, INC. (US) | 2024-04-23 | — | — | US | disclosed |
| US-20220323355-A1 | Ribose Cationic Lipids | TRANSLATE BIO MA, INC. | 2022-10-13 | — | — | US | disclosed |
| EP-3794008-A1 | RIBOSE CATIONIC LIPIDS | Translate Bio, Inc. (US) | 2021-03-24 | — | — | EP | disclosed |
| CN-112384523-A | Cationic lipid of ribose | 川斯勒佰尔公司 | 2021-02-19 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240374521-A1 | RIBOSE CATIONIC LIPIDS | RPIA, RRM2B, SARNP | L3MBTL1 228/4885MAPT 3969/4885 |
| US-11964051-B2 | Ribose cationic lipids | RPIA, RRM2B, SARNP | L3MBTL1 228/4885MAPT 3969/4885 |
| US-20220323355-A1 | Ribose Cationic Lipids | RPIA, RRM2B, SARNP | L3MBTL1 228/4885MAPT 3969/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.